Literature DB >> 1390876

Changes in fatty acid composition in rat blood and organs after infusion of eicosapentaenoic acid ethyl ester.

K Yamazaki1, T Hamazaki.   

Abstract

An infusible emulsion of 10% eicosapentaenoic acid ethyl ester (EPA-EE, 99.2% pure) was prepared. Three ml of the emulsion was infused into tail veins of 20 Wistar rats weighing approx. 300 g. They were killed 1 h, 6 h, 24 h, 3 d and 7 d after the infusion, and fatty acid composition of various organs and plasma was analyzed along with that of control rats. There was no lipidosis in any organs of any rats. It was estimated that not less than 98% of infused EPA was cleared from plasma during the first hour after the infusion. EPA concentrations reached their peaks within 6 h after EPA infusion in plasma lipid fractions and in the phospholipid fraction of liver, heart, lung, kidney and spleen. The fatty acid composition of the phospholipid fraction of heart was very stable, and was not altered by EPA infusion except for a very slight increase in EPA at 1 h after the infusion (0.18% at 0 h to 0.56%). However, EPA concentrations increased markedly in the free fatty acid fraction of heart at 1 h after the infusion (0.15% at 0 h to 4.23%). Arachidonic acid concentrations decreased significantly within 24 h in the phospholipid fraction of organs except for heart. EPA emulsion might be useful for patients in whom a rapid increment in EPA in tissues is beneficial.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1390876     DOI: 10.1016/0005-2760(92)90254-s

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Modulation of human hepatocyte acute phase protein production in vitro by n-3 and n-6 polyunsaturated fatty acids.

Authors:  S J Wigmore; K C Fearon; J A Ross
Journal:  Ann Surg       Date:  1997-01       Impact factor: 12.969

Review 2.  Fatty acid ethyl esters: nonoxidative ethanol metabolites with emerging biological and clinical significance.

Authors:  M Laposata
Journal:  Lipids       Date:  1999       Impact factor: 1.646

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.